HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
5.26
+4.23 (410.29%)
Jun 29, 2026, 4:00 PM EDT - Market closed
HCW Biologics Earnings Call Transcripts
Fiscal Year 2026
-
Key milestones included $17.5M equity raised, debt repayment, and clinical trial progress. Five shareholder proposals were approved, including director elections, auditor ratification, and warrant-related actions. Strategic focus remains on advancing clinical programs and business development.
Fiscal Year 2025
-
The meeting highlighted recent financial improvements, including new funding, debt conversion, and revenue recognition. Strategic plans focus on clinical trials and advancing immunotherapeutic compounds, with key board elections and auditor ratification completed.